Keagy B A, Starek P J, Murray G F, Battaglini J W, Lores M E, Wilcox B R
Ann Thorac Surg. 1984 Oct;38(4):314-6. doi: 10.1016/s0003-4975(10)62278-3.
Thoracotomy is not infrequently performed in patients with suspected pulmonary carcinoma but with no histological or cytological confirmation of malignancy. The intraoperative decision to proceed with major pulmonary resection (lobectomy or pneumonectomy) is difficult if a large or central lesion precludes total excisional biopsy. Incisional or needle biopsies violate the principles of good cancer surgery, and the results may be inconclusive if the tumor is missed and areas of associated inflammation or necrosis are sampled. Between January 1, 1970, and December 31, 1980, 303 patients underwent thoracotomy for suspected but unconfirmed malignancy. One hundred twenty-two had a minor resection only, 79 had a major resection (lobectomy or pneumonectomy) after a diagnosis was established by frozen section, and 102 had a major resection without a definitive diagnosis of cancer. Carcinoma subsequently was found in 68% (69) of this group of 102 patients, and benign lesions were identified in the remaining 32% (33), all of whom underwent lobectomy. The diagnoses in these 33 patients included seven granulomas, three hamartomas, nine instances of tuberculosis, and fourteen instances of fibrosis, inflammation, or cystic degeneration. The 2 thirty-day operative deaths in this group of 102 patients occurred among the 69 with malignant disease; 1 died of hemorrhage following pneumonectomy and 1, of respiratory insufficiency after lobectomy. In all 303 patients, there was no difference in operative mortality (p less than 0.01) between lobectomy (2%) and a lesser resection (1.6%). In a patient with a suspicious but inaccessible pulmonary lesion, lobectomy can be performed safely without violating the principles of cancer surgery. This recommendation should probably not be extended to lesions requiring pneumonectomy, because of the increased rates of morbidity and mortality associated with that procedure.
对于疑似肺癌但未获得组织学或细胞学恶性肿瘤确诊的患者,开胸手术并不罕见。如果大的或中央型病变妨碍进行完整切除活检,术中决定是否进行主要的肺切除术(肺叶切除术或全肺切除术)就会很困难。切开活检或针吸活检违反了良好癌症手术的原则,如果未取到肿瘤组织而取到相关炎症或坏死区域的组织,结果可能无法确诊。在1970年1月1日至1980年12月31日期间,303例患者因疑似但未确诊的恶性肿瘤接受了开胸手术。122例仅进行了小范围切除,79例在通过冰冻切片确诊后进行了主要切除(肺叶切除术或全肺切除术),102例在未明确诊断为癌症的情况下进行了主要切除。随后在这102例患者中的68%(69例)发现了癌症,其余32%(33例)为良性病变,所有这些患者均接受了肺叶切除术。这33例患者的诊断包括7例肉芽肿、3例错构瘤、9例肺结核以及14例纤维化、炎症或囊性变。在这102例患者中,2例30天手术死亡发生在69例患有恶性疾病的患者中;1例死于全肺切除术后出血,1例死于肺叶切除术后呼吸功能不全。在所有303例患者中,肺叶切除术(2%)和小范围切除术(1.6%)的手术死亡率没有差异(p<0.01)。对于肺部病变可疑但难以触及的患者,可以在不违反癌症手术原则的情况下安全地进行肺叶切除术。由于与该手术相关的发病率和死亡率增加,这一建议可能不适用于需要进行全肺切除术的病变。